Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

Last updated: April 24, 2025
Sponsor: Centre Francois Baclesse
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pelvic Cancer

Endometrial Cancer

Vaginal Cancer

Treatment

Multidisciplinary assessment

Observational cohort

Standard assesment

Clinical Study ID

NCT06553612
2023-A02554-41
  • Ages > 18
  • Female

Study Summary

This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient > 18 years

  • Patients in remission from first-line treatment of endometrial orovarian/tumor/peritoneal cancer.

  • Patient who has completed her initial treatment; patients on maintenance therapy areeligible.

  • Fluency in French

  • Patient with access to a telephone line

  • Patient affiliated to a social security scheme

  • Signature of informed consent prior to any specific study procedure

Exclusion

Exclusion Criteria:

  • Any associated medical or psychiatric condition that could compromise the patient'sability to participate in the study

  • Patient with locoregional or metastatic recurrence

  • Patient deprived of liberty, under guardianship or curatorship

  • Simultaneous participation in a therapeutic clinical trial

Study Design

Total Participants: 268
Treatment Group(s): 3
Primary Treatment: Multidisciplinary assessment
Phase:
Study Start date:
June 07, 2024
Estimated Completion Date:
June 07, 2028

Connect with a study center

  • CHU, Besançon

    Besançon,
    France

    Site Not Available

  • François Baclesse

    Caen,
    France

    Active - Recruiting

  • Centre Jean Perrin

    Clermont Ferrand,
    France

    Site Not Available

  • Centre Léon Bérard

    Lyon,
    France

    Site Not Available

  • Hopital Diaconesses Croix Saint-Simon

    Paris,
    France

    Site Not Available

  • Hopital Europeen George Pompidou

    Paris,
    France

    Site Not Available

  • Hôpital COCHIN

    Paris,
    France

    Site Not Available

  • Institut Curie

    Paris,
    France

    Site Not Available

  • Hopital privé des Côtes d'Armor

    Plérin,
    France

    Site Not Available

  • CHU, Saint Etienne

    Saint Etienne,
    France

    Site Not Available

  • Institut Curie, St Cloud

    St Cloud,
    France

    Site Not Available

  • Institut de Cancérologie de Strasbourg

    Strasbourg,
    France

    Site Not Available

  • Gustave Roussy

    Villejuif,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.